Prehospital Blood Product Transfusion in Traumatic Hypovolemic Shock: Advantages Over Crystalloid Resuscitation and Implications for Rural Trauma Care
Aaron Spearman
Background: Traumatic hypovolemic shock remains a major cause of preventable early death after injury, and prehospital resuscitation strategy can significantly affect survival1. Recent trauma literature has moved away from large-volume crystalloid resuscitation because crystalloids do not restore oxygen-carrying capacity or coagulation factors and may worsen dilutional coagulopathy1. In contrast, prehospital blood product transfusion provides earlier hemostatic and oxygen-delivery support and is associated with decreased mortality1. Despite this, fewer than 1% of US 911 ground EMS agencies have implemented prehospital blood transfusion programs3. Current literature increasingly suggests outcome advantages with prehospital blood, but important questions remain regarding implementation, access, and which patient populations benefit most, especially in rural systems with prolonged transport times3.
Methods: A comprehensive literature search was conducted using PubMed, focusing on studies published between 2017 and 2025. Keywords included “prehospital blood product transfusion,” “traumatic hemorrhagic shock,” and “prehospital blood versus crystalloid.”
Results: The reviewed literature supports a benefit of prehospital blood product administration over crystalloid-only resuscitation in trauma patients at risk for hemorrhagic shock1. Comparative findings from an analysis of the groundbreaking Prehospital Air Medical Plasma (PAMPer) study indicated that patients receiving prehospital packed red blood cells and plasma were 62% more likely to survive 30 days when compared to crystalloid-only resuscitation1. More recent publications further suggest that earlier blood administration in the prehospital setting is beneficial, especially when transport times are greater than 20 minutes5. Hemorrhage patients receiving standard crystalloid therapy had a significant increase in mortality when transport times were greater than 20 minutes; this increase in mortality was not observed in patients who received prehospital blood products5. The literature also identifies barriers to broader adoption, including storage requirements, cost, wastage concerns, and logistical constraints.3
Conclusions: Prehospital blood product transfusion programs are worth expanding because they enable earlier hemostatic resuscitation, improve physiologic indicators of shock, and are associated with better survival outcomes1,2. These programs may offer the greatest benefit in rural areas with long transport times, where delays to hospital-based transfusion are greatest and prehospital intervention can close a critical treatment gap5. Future research should further evaluate rural-specific outcomes, cost-effectiveness, product wastage reduction, and optimal patient selection to guide broader implementation3.
Works Cited:
[1] Rajesh, A., Barry, L., Giersch, C., Danko, K. L., Bowers, A., Braverman, M., Epley, E., Rose, T., Whole Blood Consortium, S. A., Eastridge, B., & Jenkins, D. (2025). Prehospital whole blood transfusion improves probability of survival over transfusion within one hour of arrival to a trauma center. The American Journal of Surgery, 250, 116530. https://doi.org/10.1016/j.amjsurg.2025.116530
[2] Guyette, F. X., Sperry, J. L., Peitzman, A. B., Billiar, T. R., Daley, B. J., Miller, R. S., Harbrecht, B. G., Claridge, J. A., Putnam, T., Duane, T. M., Phelan, H. A., & Brown, J. B. (2019). Prehospital blood product and crystalloid resuscitation in the severely injured patient: A secondary analysis of the prehospital air medical plasma trial. Annals of Surgery, 273(2), 10.1097/SLA.0000000000003324. https://doi.org/10.1097/SLA.0000000000003324
[3] Schaefer, R. M., Bank, E. A., Krohmer, J. R., Haskell, A., Taylor, A. L., Jenkins, D. H., & Holcomb, J. B. (2024). Removing the barriers to prehospital blood: a roadmap to success. Journal of Trauma and Acute Care Surgery, 97(2). https://doi.org/10.1097/ta.0000000000004378
[4] Duchesne, J., McLafferty, B. J., Broome, J. M., Caputo, S., Ritondale, J. P., Tatum, D., Taghavi, S., Olan Jackson-Weaver, Tran, S., McGrew, P., Harrell, K. N., Smith, A., Nichols, E., Dransfield, T., Marino, M., & Piehl, M. (2024). Every minute matters: Improving outcomes for penetrating trauma through prehospital advanced resuscitative care. The Journal of Trauma and Acute Care Surgery. https://doi.org/10.1097/ta.0000000000004363
[5] Sperry, J. L., Guyette, F. X., Brown, J. B., Yazer, M. H., Triulzi, D. J., Early-Young, B. J., Adams, P. W., Daley, B. J., Miller, R. S., Harbrecht, B. G., Claridge, J. A., Puyana, J. C., Alarcon, L. H., & Peitzman, A. B. (2020). Association of prehospital plasma transfusion with survival in trauma patients with hemorrhagic shock when transport times are longer than 20 minutes. JAMA Surgery, 155(2), 122–129. https://doi.org/10.1001/jamasurg.2019.3955
[6] Jouffroy, R., & Vivien, B. (2020). Prehospital Plasma Transfusion and Survival in Trauma Patients With Hemorrhagic Shock. JAMA Surgery. https://doi.org/10.1001/jamasurg.2020.1131